1. Home
  2. MCS vs VNDA Comparison

MCS vs VNDA Comparison

Compare MCS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$19.13

Market Cap

590.8M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.24

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCS
VNDA
Founded
1935
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
590.8M
474.0M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
MCS
VNDA
Price
$19.13
$7.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$23.75
$14.90
AVG Volume (30 Days)
112.9K
1.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$758,458,000.00
$216,105,000.00
Revenue This Year
$12.05
$21.35
Revenue Next Year
$3.15
$37.40
P/E Ratio
$25.18
N/A
Revenue Growth
3.11
8.72
52 Week Low
$12.85
$3.81
52 Week High
$19.49
$9.91

Technical Indicators

Market Signals
Indicator
MCS
VNDA
Relative Strength Index (RSI) 70.88 46.98
Support Level $14.66 $7.12
Resistance Level N/A $8.29
Average True Range (ATR) 0.50 0.32
MACD 0.17 0.03
Stochastic Oscillator 87.79 56.55

Price Performance

Historical Comparison
MCS
VNDA

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: